Stock Institutional Ownership and Shareholders

SecurityENZN / Enzon Pharmaceuticals, Inc. (293904108)
Institutional Owners2
Institutional Shares2,456,227
Outstanding Shares44,215,000 (as of 2017-09-30)
Institutional Value$ 10,000 USD

Enzon Pharmaceuticals, Inc. (OTC:ENZN) has 2 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,456,227 shares. Largest shareholders include Couchman Jonathan, and Panagora Asset Management Inc.



Enzon Pharmaceuticals, Inc. (OTC:ENZN) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev Shares Current Shares Change
(Percent)
Prev Value (x$1000) Current Value (x$1000) Change
(Percent)
2017-11-14 13F-HR PANAGORA ASSET MANAGEMENT INC 51,280 41,925 -18.24 19 10 -47.37
2017-05-24 SC 13G COUCHMAN JONATHAN 2,414,302
CUSIP: 293904108